Immunology, Virology, and Immunogenetics of Multiple Sclerosis.- Immunocyte Abnormalities in Multiple Sclerosis.- Different T-Cell Response to Myelin Basic Protein in Multiple Sclerosis Patients and in Healthy Subjects.- Glial Cells and Products of Activated Inflammatory Cells: Implications for Pathogenesis and Treatment of Multiple Sclerosis.- Intrathecal IgG Synthesis in Multiple Sclerosis: Correlation with Clinical Parameters.- Loss of Reliability and Sensitivity of Agarose Isoelectric-Focusing and Quantitative Formulae in the Detection of Intrathecally Synthesized IgG in the Presence of Blood-Brain Barrier Damage.- Lymphocyte Subpopulations as Markers of Disease Activity in Multiple Sclerosis.- Serological Studies of Patients with Multiple Sclerosis, Controls, and Patients with Other Neurological Diseases: Antibodies to HTLV-I, HTLV-II, HIV, and STLV-III.- Correlation of Oligoclonal IgG Bands and Viral Antibodies in Twins with Multiple Sclerosis.- Detection of HLA Class II Restriction Fragment Length Polymorphisms in Multiple Sclerosis Using Pooled DNA Samples.- HLA Studies in the Multiple Sclerosis Population.- Multiple Sclerosis: Phenotypic Immunogenetic Markers and Nucleic Acid Biochemistry.- Genetics in Multiple Sclerosis - with Special Emphasis on Twin Studies.- Risk Factors, Course, Prognosis, and Treatment of Multiple Sclerosis.- Risk Factors, Course and Prognosis of Multiple Sclerosis.- Epidemiological Studies of Multiple Sclerosis in Western Norway: Possible Factors in Etiology and Prognosis.- Multiple Sclerosis: Stochastic Models of Prognosis.- Studies of the Natural History of Multiple Sclerosis.- Space-Time Aggregation in a Small Village in Italy: Buti (Pisa).- Immunotherapy in Multiple Sclerosis: Arguments for Early Treatment.- SelectiveImmunosuppression in Multiple Sclerosis.- Use of Azathioprine in Multiple Sclerosis.- Immunosuppression with Azathioprine in Multiple Sclerosis.- Multiple Sclerosis: Preliminary Reports of a Therapeutical Trial and Magnetic Resonance Imaging Correlates.- New Trends for Treatment in Multiple Sclerosis.- Short Communications.- Limitations of Peroxidase Staining in the Detection of CSF IgA Separated by Agarose Isoelectric Focusing.- Failure to Detect Anti-HTLV-III Antibodies in Serum and CSF of 84 Neurological Patients.- Absence of Serum-HTLV-I and -III Antibodies in Multiple Sclerosis Patients.- Antigen Histocompatibility (HLA) in Multiple Sclerosis Patients from Gorski Kotar, Yugoslavia.- Diagnostic and Predictive Value of Nonclinical Tests in Retrobulbar Optic Neuritis.- Contribution of Magnetic Resonance Imaging in the Assessment of Multiple Sclerosis.- Serial Evoked Potentials and Disease Progression in Multiple Sclerosis.- Clinical and Immunological Findings After Treatment with Thymostimulin in Multiple Sclerosis.- Treatment of Multiple Sclerosis with a Mega Dose of 6-Methylprednisolone.- Long-Term Hyperbaric Oxygen in Chronic Progressive Multiple Sclerosis: A Placebo-Controlled Double-Blind Randomized Study with Evoked Potential Evaluation.- Psychotherapy in Patients with Multiple Sclerosis.- Cognitive Impairment in Multiple Sclerosis.
